For institutions & investigators

Propose a co-discovery or validation study

Every signature on this site has cleared the field's public benchmarks and is still unvalidated in an Indian population — that gap is the opportunity. We work with hospitals, pharma and academic groups holding characterised cohorts, under a governed data-sharing and co-authorship framework, with your institution retaining clinical oversight throughout.

Bioinformatics partnership
Share cohort data; we return biomarker and mechanistic insight — the fastest way to start.
Co-development
Validate a MANTRA-designed test on your cohort, under your clinical oversight.
Co-discovery
Define an India-specific signature from scratch on your own biopsy/stool records, jointly held IP.
Write to us
jagriti@mahanim.in

To help us come back with the right partnership model, tell us:

  • Your institution or organisation
  • The cohort, data or product you're working with
  • The clinical question you'd like to answer
Email us
How a study runs

From first call to publication

01

Scoping call

Your clinical question, your cohort, and the data types you hold.

02

Agreements & approvals

Data-sharing agreement, ethics approval, and co-authorship and IP terms settled up front.

03

Pre-registered plan

The comparisons and success criteria are fixed before any analysis begins.

04

Discovery & joint review

We run the analysis; your clinicians interpret the findings with us.

05

Publication & translation

A co-authored paper, then validation and product development for the findings that hold up.

Your data stays under your institution's governance and is used only for the agreed study.

Microbes differ. Disease pathways converge.
That's where precision medicine starts: with MANTRA.
© 2026 Mahanim Biologics Private Limited · CIN [CIN] · [Registered office address] · Patent filing in progress · jagriti@mahanim.in
Home Applications Evidence Publications Team For investors